Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Astellas Pharma China, Inc., explained in plain language.
This study tested whether adding enzalutamide to standard hormone therapy (ADT) helps Chinese men with prostate cancer that has spread but still responds to hormones. 180 participants received either enzalutamide plus ADT or a placebo plus ADT. The goal was to see if the combinat…
Phase: PHASE3 • Sponsor: Astellas Pharma China, Inc. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC